SynthesisPloS one2013

The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis.

Zi-Xu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.